BSN and non-small cell lung carcinoma: We found that BSN suppressed both constitutive and IL-6-inducible STAT3 activation; down-regulated STAT3-regulated gene products; and potentiated paclitaxel-induced apoptotic effects in NSCLC both in vitro and in vivo.